ERBB2 and breast carcinoma: Modi Modi S S Saura Saura C C Yamashita Yamashita T T Trastuzumab deruxtecan in previously treated HER2-positive breast cancer Trastuzumab deruxtecan in previously treated HER2-positive breast cancer N Engl J Med N Engl J Med 2020 2020 382 382 7 7 610 610 621 621 10.1056/NEJMoa1914510 10.1056/NEJMoa1914510 supplied-pmid 31825192?